# Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome

> **NCT04351906** · NA · COMPLETED · sponsor: **University of Giessen** · enrollment: 20 (actual)

## Conditions studied

- ARDS
- Hypercapnic Respiratory Failure
- AKI

## Interventions

- **DEVICE:** ECCO2R

## Key facts

- **NCT ID:** NCT04351906
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-03
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351906, "Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04351906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*